STOKStoke Therapeutics, Inc.
$25.01-27% 1Y
$25.01
$22.3752 weeks$38.35
Is the price fair?
What STOK's price assumes
Stoke Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 58.5× revenue.
58.5
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 4.67
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 48.2
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 4.67
- EV / EBIToperating margin −810%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 48.2
- Market capitalisation64.5 million shares, counted Jul 30, 2026
- $1.61B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks